Assessment of potential drug–drug interactions in cancer patients in a tertiary care hospital

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational assessment identified 115 pDDIs in cancer patients, highlighting risks associated with multiple medications.

A total of 115 pDDIs were identified in 41% of patients receiving cancer chemotherapy, indicating significant risk.
Moderate interactions accounted for 56% while major interactions made up 44%, underscoring the severity of findings.
The study utilized statistical methods including Mann–Whitney U and Chi-square for analyzing potential interactions.
Screening for pDDIs is essential to reduce the risk of adverse drug reactions in cancer patients during treatment.

Nambiar et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark